A team of chemists and microbiologists from the University of Leicester has developed a new method of rapidly diagnosing the infection Clostridium difficile (C. difficile).
A team of chemists and microbiologists from the University of Leicester has developed a new method of rapidly diagnosing the infection Clostridium difficile (C. difficile).1 This bacterium causes diarrhoea and is a particular problem in hospitals, where immuneâcompromised patients are particularly susceptible to it. The bacterium is resilient and can live for weeks or longer on surfaces; thus, if it is not rapidly identified and contained, it can spread quickly.
Photo Credit: MedicalRF.com/Getty Images
The new method uses the fact that these microorganisms produce metabolic volatile organic compounds (VOCs) during growth and in other processes. By analyzing the headspace above a C. difficile sample, the organism can be identified. This test is carried out using proton transfer reactionâtime of flight-mass spectrometry (PTR–TOF–MS). In this technique, the additional proton in a hydronium ion has a higher affinity for the VOCs than it does for water, which results in the organic compound becoming charged, after which it can be detected in the mass spectrometer. The ionization technique, which uses H3O+, is relatively gentle, so most peaks in the mass spectrum are assumed to be from protonated molecular ions.
In essence, this method is “fingerprinting” air, by identifying and measuring the quantity of the volatile organic compounds present. Thus, the diarrhoea of a person suffering from C. difficile would give off different VOCs than a sample from an uninfected person. Standard immunoassay tests currently in use for C. difficile diagnosis under national guidelines in the UK usually take 24–48 h. However, this new test can take as little as 5 minutes. This test can also differentiate between strains of the bacteria (not all of which are pathogenic) because different types of C. difficile produce different mass spectra. This differentiation information is not provided by standard tests currently in use.
Professor Paul Monks, a professor of analytical chemistry at Leicester and who is a member of the research team at Leicester, said that further development is necessary before the method can be applied in a clinical setting. “It will require some time and investment before a cheap, simple, and practical sensor can be developed that will give a simple yes-no answer on a sample,” he said. “The good news is that this may only take a couple of years, a very short time in the context of clinical advances.”
The fundamental principle of this technique can also be applied to a wide range of areas, such as to track air pollution, or to test breath in order to determine the length of time since someone last had an alcoholic drink, or even to tell when mangoes are ripe. Over the next few years we could see a rise in the development of a variety of applications for this method of “fingerprinting air”.
Reference
Analyzing Bone Proteins in Forensic Laboratories Using LC−MS/MS
November 4th 2024A recent study compared different workflows for extracting, purifying, and analyzing bone proteins using liquid chromatography with tandem mass spectrometry (LC–MS/MS), including an in-StageTip protocol previously optimized for forensic applications, and two protocols using novel suspension-trap technology (S-Trap) and different lysis solutions. LCGC International discussed this work with Noemi Procopio of the School of Law and Policing and the Research Centre for Field Archaeology and Forensic Taphonomy at the University of Central Lancashire (UK), corresponding author of the paper that resulted from this study.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Profiling Volatile Organic Compounds in Whisky with GC×GC–MS
November 1st 2024Researchers from Austria, Greece, and Italy conducted a study to analyze volatile organic compounds (VOCs) present in Irish and Scotch whiskys using solid-phase microextraction (SPME) Arrow with comprehensive two-dimensional gas chromatography coupled to mass spectrometry (GC×GC–MS) to examine the organoleptic characteristics that influence the taste of spirits.